Literature DB >> 6220063

Cellular basis of defective cell-mediated lympholysis in atopic dermatitis.

D Y Leung, N Wood, D Dubey, A R Rhodes, R S Geha.   

Abstract

Peripheral blood lymphocytes (PBL) from patients with atopic dermatitis (A.D.) were examined for their capacity to generate cytotoxic T lymphocytes (CTL) during mixed lymphocyte cultures (MLC). Cell-mediated lympholysis (CML) activity, but not proliferative response during MLC, was significantly decreased (p less than 0.01) in patients with A.D. (n = 19) compared with normal controls (n = 19) or patients with other skin diseases (n = 14). Regression analysis revealed a significant correlation (p less than 0.001) between CML activity and the percentage of circulating T8+ suppressor/cytotoxic T cells. Deficient CML activity in A.D. patients, however, was not corrected when isolated autologous T4+ and T8+ cells were recombined at a normal ratio (2:1) of T4+ to T8+ cells. Examination of CML activity in co-cultures of isolated T4+ and T8+ cells obtained from two A.D. patients and their respective HLA-identical healthy siblings indicated that the defect in CML resided in both the helper/inducer T4+ cells and the effector T8+ cells. The defective cytotoxic T cell function reported in the present study may account for the increased susceptibility of patients with A.D. to develop severe viral infections.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6220063

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Immunopathology of atopic dermatitis.

Authors:  D Y Leung
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Decreased monocyte production of interleukin-1 and impaired lymphocyte proliferation in atopic dermatitis.

Authors:  L Räsänen; M Lehto; T Reunala; C Jansen; P Leinikki
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

Review 3.  Immunoregulatory abnormalities in atopic dermatitis.

Authors:  D Y Leung; R S Geha
Journal:  Clin Rev Allergy       Date:  1986-02

4.  Interleukin 2 therapy in severe atopic dermatitis.

Authors:  K H Hsieh; C C Chou; S F Huang
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

5.  Impairment of the autologous mixed lymphocyte reaction in atopic dermatitis.

Authors:  D Y Leung; J A Saryan; R Frankel; M Lareau; R S Geha
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

6.  Imbalance of CD4+CD45R+ and CD4+CD29+ T helper cell subsets in patients with atopic diseases.

Authors:  U Schauer; T Jung; J Heymanns; C H Rieger
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

7.  Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.

Authors:  R Karttunen; T Nurmi; J Ilonen; H M Surcel
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

8.  Thymopentin treatment in severe atopic dermatitis--clinical and immunological evaluations.

Authors:  K H Hsieh; M F Shaio; T N Liao
Journal:  Arch Dis Child       Date:  1992-09       Impact factor: 3.791

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.